AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FIREBRICK PHARMA LTD

0.031

0.000

Volume:- -

Turnover:- -

Market Cap:8.90M

PE:-2.57

High:0.031

Open:0.031

Low:0.031

Close:0.031

52wk High:0.074

52wk Low:0.024

Shares:287.20M

Float Shares:106.88M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.012

EPS(LYR):-0.012

ROE:-189.19%

ROA:-92.99%

PB:5.29

PE(LYR):-2.58

Loading ...

Overview Company News Filings

Blue Owl Capital (OWL) Stock Faces Margin Strain Despite Fee Growth

Simply Wall St.

Firebrick Pharma Ltd-change of Address

THOMSON REUTERS

Firebrick Pharma Ltd-Nasodine Composition Patent Granted in New Zealand

THOMSON REUTERS

Firebrick Pharma Ltd-Close of Offer - Listing Options

THOMSON REUTERS

Firebrick Pharma Ltd - Nasodine Patent Accepted in Canada

THOMSON REUTERS

Firebrick Pharma Ltd-Firebrick Investor Webinar Update

THOMSON REUTERS

BRIEF-Firebrick Pharma Secures A$1.5 Million Via Placement

Firebrick Pharma Ltd - Firebrick Secures a$1.5 Mln via Placement

THOMSON REUTERS

BRIEF-Firebrick Pharma Agrees And Approves Of Nasodine In Indonesia

BRIEF-Firebrick Pharma Requests Trading Halt Pending Placement Announcement

Firebrick Pharma Ltd - Approval Allows Importation and Marketing of Nasodine Nasal Spray in Indonesia

THOMSON REUTERS

Firebrick Pharma Ltd - Registration Agreement and Approval of Nasodine in Indonesia

THOMSON REUTERS

BUZZ-Australia's Firebrick Pharma gains on patent acceptance in the Philippines

Firebrick Pharma Ltd - Nasodine Patent Accepted in Philippines

THOMSON REUTERS

Firebrick Pharma Ltd-Fre Appoints Head of Business Development and Licensing

THOMSON REUTERS

Firebrick Pharma Ltd-Firebrick Appoints New Independent Director

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/FRE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.031,"timestamp":1789603404894,"preClose":0.031,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":106875635,"shares":287198985,"eps":-0.012043,"marketStatus":"Trading","change":0,"latestTime":"09-17 11:33:17 AEST","open":0.031,"high":0.031,"low":0.031,"amount":0,"amplitude":0,"askPrice":0.032,"askSize":35000,"bidPrice":0.03,"bidSize":202877,"shortable":3,"etf":0,"ttmEps":-0.012043,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789624800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"FRE.AU","preClose":0.03,"auctionPrice":0.03,"auctionVolume":2000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789106415591}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":106875635,"roa":"-92.99%","roe":"-189.19%","lyrEps":-0.012,"shares":287198985,"dividePrice":0,"high":0.031,"amplitude":0,"preClose":0.031,"low":0.031,"week52Low":0.024,"pbRate":"5.29","psRate":"65.65","week52High":0.074,"institutionHeld":0,"latestPrice":0.031,"committee":0.70573,"eps":-0.012043,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.012043,"open":0.031,"prevYearClose":0.053,"prevWeekClose":0.03,"prevMonthClose":0.035,"prevQuarterClose":0.036,"fiveDayClose":0.03,"twentyDayClose":0.027,"sixtyDayClose":0.033},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656392944","title":"Blue Owl Capital (OWL) Stock Faces Margin Strain Despite Fee Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656392944","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656392944?lang=en_us&edition=fundamental","pubTime":"2026-08-01 07:23","pubTimestamp":1785540193,"startTime":"0","endTime":"0","summary":"Blue Owl Capital stock inched up about 1.4% to US$10.30 after earnings, a relatively calm move for a company that just put a very rich 86x P/E and an almost 9% dividend yield back under the microscope. The headline this quarter is margin pressure. Quarterly basic EPS landed at a little under US$0.02 and trailing net profit margin sits at 2.7%, with results still carrying the weight of a US$262.4m one off loss.\nShort term traders may focus on the modest price gain. Long term holders will be...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-owl/blue-owl-capital/news/blue-owl-capital-owl-stock-faces-margin-strain-despite-fee-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-owl/blue-owl-capital/news/blue-owl-capital-owl-stock-faces-margin-strain-despite-fee-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BBT3K403.USD","OWL","PEVC","PSP","IE00BLSP4452.SGD","BK7096","IE00BLSP4239.USD","IE00BN8TJ469.HKD","BK4135","FRE.AU","LRCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651230241","title":"Firebrick Pharma Ltd-change of Address","url":"https://stock-news.laohu8.com/highlight/detail?id=2651230241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651230241?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:00","pubTimestamp":1783994410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUE1QJP9W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640489929","title":"Firebrick Pharma Ltd-Nasodine Composition Patent Granted in New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2640489929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640489929?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:20","pubTimestamp":1780438854,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUE7SLL2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636816352","title":"Firebrick Pharma Ltd-Close of Offer - Listing Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2636816352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636816352?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:50","pubTimestamp":1779259828,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUE5XSD6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635022012","title":"Firebrick Pharma Ltd - Nasodine Patent Accepted in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2635022012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635022012?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:18","pubTimestamp":1778638723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41P1MW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629624200","title":"Firebrick Pharma Ltd-Firebrick Investor Webinar Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629624200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629624200?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:02","pubTimestamp":1776819753,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUE7MNHNK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623908376","title":"BRIEF-Firebrick Pharma Secures A$1.5 Million Via Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623908376","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623908376?lang=en_us&edition=fundamental","pubTime":"2026-03-31 09:53","pubTimestamp":1774921995,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Secures A$1.5 Million Via PlacementMarch 31 (Reuters) - Firebrick Pharma Ltd FRE.AX:FIREBRICK SECURES A$1.5 MILLION VIA PLACEMENTPLACEMENT SHARES ISSUED AT A$0.047 PER SHAREFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623322329","title":"Firebrick Pharma Ltd - Firebrick Secures a$1.5 Mln via Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623322329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623322329?lang=en_us&edition=fundamental","pubTime":"2026-03-31 06:13","pubTimestamp":1774908787,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I1CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622813227","title":"BRIEF-Firebrick Pharma Agrees And Approves Of Nasodine In Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2622813227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622813227?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:23","pubTimestamp":1774574628,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Agrees And Approves Of Nasodine In IndonesiaMarch 27 (Reuters) - Firebrick Pharma Ltd FRE.AX:REGISTRATION AGREEMENT AND APPROVAL OF NASODINE IN INDONESIAAPPROVAL ALLOWS IMPORTAT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622894712","title":"BRIEF-Firebrick Pharma Requests Trading Halt Pending Placement Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622894712?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:18","pubTimestamp":1774563498,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Requests Trading Halt Pending Placement AnnouncementMarch 27 (Reuters) - Firebrick Pharma Ltd FRE.AX:REQUESTS TRADING HALT PENDING PLACEMENT ANNOUNCEMENTFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622894917","title":"Firebrick Pharma Ltd - Approval Allows Importation and Marketing of Nasodine Nasal Spray in Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622894917?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:55","pubTimestamp":1774562130,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622894910","title":"Firebrick Pharma Ltd - Registration Agreement and Approval of Nasodine in Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622894910?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:55","pubTimestamp":1774562130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620400288","title":"BUZZ-Australia's Firebrick Pharma gains on patent acceptance in the  Philippines","url":"https://stock-news.laohu8.com/highlight/detail?id=2620400288","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620400288?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:20","pubTimestamp":1773800454,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Firebrick Pharma gains on patent acceptance in the PhilippinesUpdates** Shares of Australia's Firebrick Pharma FRE.AX rise 5.5% to A$0.058, set for their best day since March 4 if trend holds ** Co says its patent, which protects the use of Nasodine nasal spray or any other intranasal povidone-iodine preparations as a method of reducing the viral load of SARS-CoV-2 in the nose, has been approved in the Philippines ** FRE is currently seeking regulatory approval in the Philippines and anticipates approval during 2026** Shares up 9.4% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL6N40604P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620405707","title":"Firebrick Pharma Ltd - Nasodine Patent Accepted in Philippines","url":"https://stock-news.laohu8.com/highlight/detail?id=2620405707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620405707?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:38","pubTimestamp":1773783505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4050R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620492379","title":"Firebrick Pharma Ltd-Fre Appoints Head of Business Development and Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620492379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620492379?lang=en_us&edition=fundamental","pubTime":"2026-03-17 05:22","pubTimestamp":1773696132,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUE9XVJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610457666","title":"Firebrick Pharma Ltd-Firebrick Appoints New Independent Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2610457666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610457666?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:19","pubTimestamp":1770671989,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUEBTJYXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","FRE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}